Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Differentiation of bone marrow-derived mesenchymal stem cells from diabetic patients into insulin-producing cells in vitro.

Chinese medical journal - 5 May 2007

Sun Yu, Chen Li, Hou Xin-guo, Hou Wei-kai, Dong Jian-jun, Sun Lei, Tang Kuan-xiao, Wang Bin, Song Jun, Li Hui, Wang Ke-xin

Abstract excerpt

BACKGROUND: Stem cells, which have the ability to differentiate into insulin-producing cells (IPCs), would provide a potentially unlimited source of islet cells for transplantation and alleviate the major limitations of availability and allogeneic rejection. Therefore, the utilization of stem cells is becoming the most promising therapy for diabetes mellitus (DM). Here, we studied the differentiation capacity of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bone Marrow Cells
Share to Cell Differentiation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Diabetes Mellitus

Share to Glucose

Share to Insulin

Share to Islets of Langerhans Transplantation

Share to Mesenchymal Stem Cells

Share to Phenotype

Source

Identifiers

PMID: 17531117

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Differentiation of bone marrow-derived mesenchymal stem cells from diabetic patients into insulin-producing cells in vitro.PMID 17531117Read ↗

Stem cells as a therapeutic target for diabetesSemantic proximity Read ↗

Generation of Insulin-Producing Cells from Human Bone Marrow Mesenchymal Stem Cells by Genetic ManipulationSemantic proximity Read ↗

Generation of insulin-producing cells from human bone marrow-derived mesenchymal stem cells: comparison of three differentiation protocols.Semantic proximity Read ↗

Tailor-made generation of insulin-producing cells from canine mesenchymal stem cells derived from bone marrow and adipose tissueSemantic proximity Read ↗

Stem cell-derived pancreatic beta cells: a step closer to functional diabetes treatment?Semantic proximity Read ↗

Differentiation of Multipotent Stem Cells to Insulin-Producing Cells for Treatment of Diabetes Mellitus: Bone Marrow- and Adipose Tissue-Derived Cells ComparisonSemantic proximity Read ↗

Diabetes treatment: A rapid review of the current and future scope of stem cell researchSemantic proximity Read ↗

Differentiation of mesenchymal stem cells derived from pancreatic islets and bone marrow into islet-like cell phenotype.Semantic proximity Read ↗

Recent Progress of Research Regarding the Applications of Stem Cells for Treating Diabetes MellitusSemantic proximity Read ↗

Pancreatic Endoderm-Derived From Diabetic Patient-Specific Induced Pluripotent Stem Cell Generates Glucose-Responsive Insulin-Secreting Cells.Semantic proximity Read ↗

Differentiation of human-induced pluripotent stem cells into insulin-producing clusters.Semantic proximity Read ↗

Directed differentiation of human iPSC into insulin producing cells is improved by induced expression of PDX1 and NKX6.1 factors in IPC progenitorsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.